Document is current
Any future updates will be listed below
-
Authors
Gray, Jhanelle E. https://orcid.org/0000-0003-1304-7062
Chiappori, Alberto
Williams, Charlie C.
Tanvetyanon, Tawee
Haura, Eric B.
Creelan, Ben C.
Kim, Jongphil
Boyle, Theresa A.
Pinder-Schenck, Mary
Khalil, Farah
Altiok, Soner
Devane, Rebecca
Noyes, David
Mediavilla-Varela, Melanie
Smilee, Renee
Hopewell, Emily L.
Kelley, Linda
Antonia, Scott J.
-
Funding
Funding for this research was provided by:
Florida Department of Health (4KB17)
National Cancer Institute (P30-CA076292)
- License Information
-
More Information
Article History
Received: 15 March 2018
Accepted: 23 August 2018
First Online: 12 September 2018
Compliance with ethical standards
:
: Scott J. Antonia, MD, Ph.D. is a scientific advisor to CBMG. All other authors have declared no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was approved by the National Institute of Health Office of Biotechnology Activities, FDA, and the Institutional Review Board and Institutional Biosafety Committee (at University of South Florida) and conducted in accordance with Good Clinical Practice standards.
: All patients gave written informed consent.
